Evogene (EVGN) Misses Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q2 EPS of ($0.85), $0.24 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $880 thousand versus the consensus estimate of $1.69 million.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Trump administration to offer $17.5 billion for nuclear reactors
- Xerox Corp. (XRX) gains on report of SEWP VI contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
